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Abstract. Stathmin is a ubiquitous cytosolic protein 
which undergoes extensive phosphorylation in re- 
sponse to a variety of external signals. It is highly abun- 
dant in developing neurons. The use of antisense oligo- 
nucleotides which selectively block stathmin expression 
has allowed us to study directly its role in rat PC12 
cells. We show that stathmin depletion prevents nerve 
growth factor (NGF)-stimulated differentiation of 
PC12 cells into sympathetic-like neurons although the 
expression of several NGF-inducible genes was not af- 
fected. Furthermore, we found that stathmin phosphor- 
ylation in PC12 cells which is induced by NGF depends 
on mitogen-activated protein kinase (MAPK) activity. 
We conclude that stathmin is an essential component of 
the NGF-induced MAPK signaling pathway and per- 
forms a key role during differentiation of developing 
neurons. 
I 
N the developing central nervous system, neurite out- 
growth as well as the elimination of neurons are es- 
sential processes underlying the formation of precise 
patterns  of synaptic connectivity (O'Leary et  al.,  1986; 
Catsicas et al., 1987; for review see Goodman and Shatz, 
1993). In an attempt to identify molecules and mechanisms 
involved in these processes, we have employed a subtrac- 
tive cloning strategy to isolate cDNAs  differentially ex- 
pressed during specific developmental stages in the chick 
retina (Lebeau et al.,  1991).  Subtracted clone D6 which 
was transiently upregulated during the period of neurite 
outgrowth and synapse formation encoded the chick ho- 
mologue of stathmin (Catsicas,  S.,  and  G.  Grenningloh, 
unpublished data). Here we describe the functional analy- 
sis of this molecule. 
Stathmin, also known as p19 (Pasmantier et al., 1986), 
prosolin  (Braverman  et  al.,  1986),  p18  (Hanash  et  al., 
1988), 19K (Gullberg et al., 1990), and Op18 (Hailat et al., 
1990) is a cytosolic protein whose phosphorylation is cor- 
related  with  the  action of multiple extracellular stimuli 
regulating proliferation and  differentiation. While these 
observations implicate  stathmin in processes  underlying 
signal transduction (for review see Sobel, 1991), a role in 
the control of cell cycle has also been proposed (Luo et al., 
1994; Brattsand et al., 1994; Marklund et al., 1994). Stath- 
min is expressed in a variety of cell types and tissues, in- 
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cluding neurons, where it is highly abundant during devel- 
opment (for review see Sobel, 1991). In rat brain, stathmin 
expression reaches a peak around birth, although its ex- 
pression remains significant in specific areas of adult brain 
(Peschanski et al., 1993; Himi et al., 1994). Previous stud- 
ies had demonstrated that stathmin is expressed in PC12 
cells where its phosphorylation, but not its expression, is 
stimulated by the addition of NGF (Doye et al., 1990). De- 
spite  considerable  interest  in  the  expression  and  phos- 
phorylation of stathmin in neurons, to date, there has been 
no direct evidence implicating this protein in specific neu- 
ronal functions. 
As a first step towards a functional analysis of stathmin 
in neurons, we have used antisense oligonucleotides to de- 
crease stathmin protein levels in rat pheochromocytoma 
PC12 cells. This cell line is considered an excellent model 
system to analyze molecular mechanisms underlying NGF- 
mediated neuronal differentiation. PC12 cells undergo dif- 
ferentiation into sympathetic-like neurons  upon chronic 
NGF treatment, exhibiting characteristic morphological and 
molecular properties  of a  neuronal phenotype  (Greene 
and Tischler, 1976). 
The intracellular signaling pathways stimulated by NGF 
are triggered after activation of the high affinity receptor 
tyrosine kinase TrkA.  Of several identified downstream 
effector targets, activation of p21ras and an associated cas- 
cade leading to activation of mitogen-activated protein ki- 
nase (MAPK)  1 family members plays an essential role in 
processes mediating neuronal differentiation (for reviews 
1. Abbreviations used in  this paper:  BrdU, bromodeoxyuridine; MAPK, 
mitogen-activated protein kinase; PON, phosphorothioate oligonucleotide. 
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Heumann, 1994; Pang et al., 1995). MAPKs phosphorylate 
a diverse range of nuclear, membranous, and cytoplasmic 
proteins (for review see Davis, 1993) although targets cru- 
cial for neurotrophic responsiveness are unknown. Inter- 
estingly, recent evidence has demonstrated that stathmin 
is a  substrate for MAPK in vitro (Leighton et al.,  1993; 
Marklund et  al.,  1993)  and may also be  a  physiological 
substrate for this kinase system in intact cells (Beretta et 
al., 1993; Marklund et al., 1993; Beretta et al., 1995). 
In this report, we have induced stathmin depletion by 
chronically exposing PC12 cells to phosphorothioate anti- 
sense oligonucleotides (PONs). We show that a selective 
blockade of stathmin expression prevented the differentia- 
tion-promoting actions of NGF.  Moreover, inhibition of 
the MAPK pathway prevented NGF-induced phosphory- 
lation of stathmin in PC12 cells.  Taken together, our re- 
sults suggest that stathmin plays a critical role in the NGF- 
activated MAPK cascade mediating withdrawal from the 
cell cycle and differentiation. 
Materials and Methods 
PCI2 Cell Culture 
PC12 cell lines were routinely cultured as described previously (Greene 
and Tischler, 1976), maintained in RPMI 1640 containing 10% horse se- 
rum and 5% FCS. 
Antisense Experiments and 
Phosphorothioates Oligonucleotides 
PC12 cells were plated in 24-well collagen-coated multi-well dishes at a 
density of 10,000  cells per well in  RPMI  1640  supplemented with  1% 
horse serum. The uptake of PONs by PC12 cells was tested with three dif- 
ferent FITC-labeled PONs (two 18-mers and one 20-mer) as previously 
described (Catsicas et al., 1995). Fluorescence was visible in more than 90% 
of the cells 24 h after the addition of PONs. To establish the dose-response, 
10  p~M  HPLC-purified  antisense or  control  PONs,  respectively, were 
added on the first day followed by I  ixM, 2 p~M, or 4 p~M every day (anti- 
sense PON ASI: 5'-ctccagctctttcacctg-3'; antisense PON AS2: 5'-tgaatat- 
cagaagatgccat-3';  nonsense PON NS: 5'-cttccc~ctgctcgctat-3';  unrelated PON 
UR: 5'-gcatgttcttggtca-3'). The second day and every other day, 50 ng/ml 
NGF was added and cells were incubated for another 5 d. The cells were 
photographed using an  Axiovert 135  microscope (Zeiss). For Western 
blot analysis, the cells were removed from the culture dish, pelleted, and 
resuspended in sample buffer for PAGE. 
Gel Electrophoresis, Immunoblotting, and Antibodies 
Proteins were  separated  on  14%  or 8-16%  SDS-PAGE after electro- 
phoretic transfer to nitrocellulose, immunoblots were immersed in block- 
ing solution consisting of 5% milk powder in PBS/0.15% Tween-20. Blots 
were subsequently incubated with one of the following antibodies diluted 
in 2.5% milk powder in PBS: rabbit anti-stathmin (Koppel et al.,  1990), 
mouse anti-actin (Boehringer Mannheim C4),  rabbit anti-VGF8a (Pos- 
senti et al., 1989; a generous gift from A. Levi, Rome), rabbit anti-periph- 
erin (Djabali et al., 1991; a generous gift from M.-M. Portier, Paris), rabbit 
anti-Gqct (Edgerton et al., 1994), and rabbit anti-SCG10. The rabbit anti- 
SCG10 serum was generated against a fusion protein containing the entire 
coding rat sequence (generous gift from N. Mori, Kyoto, Japan) fused to 
the bacterial TrpE protein (Spindler et al.,  1984). Antibody binding was 
detected using the ECL Western blotting kit (Amersham International, 
Buckinghamshire, England). The intensity of the bands on the autoradio- 
grams was quantified by optic densitometry using a 3 CCD video camera 
linked to a VIDAS (Kontron, Ztirich, Switzerland) image analyzer. The 
protein expression values were normalized to those of the Gqct protein, 
whose expression is not affected by NGF treatment which can be used as a 
marker of equal loading. In the experiment dealing with the NGF-induced 
proteins, the protein expression values were normalized to those of the 
samples treated with NGF alone, which represented arbitrarily the 100% 
values. 
Cell Counts and 
Bromodeoxyuridine-Incorporation Assay 
For cell proliferation assays, PC12 cells were plated in 24-well collagen- 
coated multi-well dishes at a density of 10,000 cells per well. Addition of 
oligos (4  p.M every day) and NGF was performed as above. Triplicate 
samples of cells were counted in a hemacytometer. For the bromodeox- 
yuridine (BrdU)-incorporation assay, BrdU was added on the fourth day 
of incubation for 40 h. Cells were transferred to slides using the cytospin 
technique, fixed, and  stained according to the manufacturer's protocol 
(Boehringer, Mannheim, Germany, BrdU labeling kit). Triplicate fields 
containing 200-300 cells were counted manually for labeled vs nonlabeled 
cells on the image analyzer. 
Analysis of  MAPK and Stathmin Phosphorylation in 
PC12 Cells 
PC12 cells were plated at 2  ×  106 cells in six-weU collagen-coated multi- 
well dishes and maintained in RPMI 1640, 0.5% horse serum for 48 h fol- 
lowed by incubation in serum-free medium for 2 h. Then, the PC12 cells 
Figure 1.  Blockade  of stathmin ex- 
pression with antisense PONs. PC12 
cells  were  maintained  in  RPMI 
1640  supplemented with  1%  horse 
serum and treated in the following 
way:  on the  first day,  10  I~M  anti- 
sense or control PONs, respectively, 
were added, followed by 1 p,M, 2 paM, 
or 4  ~M every day in parallel  sam- 
ples.  The  second  day  and  every 
other day, 50 ng/ml NGF was added 
and the cells were incubated for an- 
other 5  d. A  shows the  effect of 4 
~xM antisense PONs, AS1 and AS2, 
and 4  ~M control PONs (NS, non- 
sense and UR, unrelated) on stathmin protein levels in PC12 cells. Normalized mean gray values of the signals in Western blots (from 
three independent experiments) are shown in arbitrary units. Values denote means _+ SEM. AS1 differs statistically from NS and UR 
(P <  0.01); AS2 differs from NS (P <  0.01); and from UR (P <  0.05). B  shows the Western blot of protein extracts from cultures incu- 
bated in the absence of PON (lane 1), in the presence of antisense PON AS1, 1 p~M (lane 2), 2  ~M (lane 3), or 4  p~M (lane 4), and non- 
sense PON, 1 txM (lane 5) and 4  p~M (lane 6). Blots were incubated with antibodies specific for stathmin, actin, and Gq~c Inhibition of 
stathmin expression following antisense treatment is specific, dose-dependent, and reaches ~75%  of control values. 
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(50 ng/ml) in RPMI 1640, 1% horse serum. To inhibit MAPK kinase activ- 
ity, 20 ~M PD98059 was added 30 min before the addition of NGF (Pang 
et al.,  1995). For the analysis of MAP kinase phosphorylation, the ceils 
were subsequently washed with cold PBS and lysed by adding 100 ~1 of 
SDS sample buffer. After sonication and heat denaturation, 20 ~1 of each 
sample was loaded on an 8--16% SDS-PAGE. As controls, 25 ng of phos- 
phorylated and nonphosphorylated MAP kinase protein (New England 
Figure 2.  Effect of stathmin antisense PON AS1 on NGF-induced neurite outgrowth in PC12 cells. Phase contrast micrographs of PC12 
cells maintained in RPMI 1640 supplemented with 1% horse serum for 6 d without any addition (A), with NGF (B), with NGF and 4 ~M 
antisense PON AS1 (C), or with NGF and 4 I~M nonsense PON (D). Neurite outgrowth in response to NGF is seen only in B and D. An- 
tisense-treated cells (C) are similar to cells not induced with NGF (A). The same results were obtained in replicate experiments. Bar, 25 ~m. 
Di Paolo et al. Role of Stathmin  in PC12 Cell Differentiation  1385 Biolabs, Schwalbach, Germany) was also loaded.  After electrophoretic 
transfer to Immobilon membrane, phosphorylated MAP kinase was de- 
tected with the Phospho Plus antibody (New England Biolabs) which spe- 
cifically recognizes phosphorylated p44 and p42 MAP kinase. For analysis 
of stathmin phosphorylation, we used a native PAGE gel system that sep- 
arates stathmin according to the charge differences introduced by phos- 
phorylation (Marklund et al., 1993). 20 ~g of total protein were loaded on 
a 10% nondenaturating gel. Western blotting was performed as described 
above. 
Results 
Inhibition of Stathmin Expression  in PCI2 Cells 
To block stathmin expression, we chronically added to the 
culture medium phosphorothioate-modified antisense oli- 
gonucleotides (PONs) complementary to position 1 to 20 
(AS2) and 19 to 36 (AS1) relative to the translation initia- 
tion  site of the rat  stathmin coding region  (Doye et al., 
1989; Schubart et al., 1989). Controls included a nonsense 
(NS) and an unrelated  (UR) PON. Western blot experi- 
ments and subsequent measurements of protein levels by 
optic densitometry of the  autoradiograms  allowed  us to 
monitor stathmin expression after the addition of PONs at 
different  concentrations.  The  two  antisense  PONs  were 
able to decrease significantly stathmin protein levels be- 
tween  50  (AS2)  and 75%  (AS1)  in  a  specific and  dose- 
dependent manner (Fig. 1 and data not shown). Fig. 1, A 
and B show that the strong decrease in expression of stath- 
min  after one week  of antisense  treatment was  not  ob- 
served in cells treated with control PONs, and that the ex- 
pression of internal control proteins was not affected by 
the antisense PONs. 
Stathmin Antisense Treatment Blocks PC12 
Cell Differentiation 
Visual inspection of cultures treated with the antisense PONs 
revealed an apparent inability of the PC12 cells to respond 
to NGF.  The most dramatic effects were observed with 
PON AS1, which correlated with its efficiency in inhibiting 
stathmin expression by 75%  (Fig. 2). Whereas in control 
PON-treated cultures, cells extended processes after 5 d of 
NGF exposure,  no  neurite  outgrowth  was  detectable  in 
cultures  treated  with  antisense  PON  AS1  and  the  cells 
maintained  the  characteristic  round  shape,  phase-bright 
feature of proliferating PC12 cells (Fig. 2). Furthermore, 
we found a consistent and significant increase in the num- 
ber of cells in the antisense-treated  cultures in the pres- 
ence of NGF. When cultures were treated with antisense 
PON AS1, the number of cells at the end of the treatment 
was increased by a factor of 3.5 to 4, whereas in the pres- 
ence of NGF and control PONs, we found only a twofold 
increase in cell number. 
Since these experiments were performed in differentia- 
tion medium containing only 1%  horse serum where the 
proliferation rate of PC12 cells is reduced, we then mea- 
sured PC12 cell proliferation using the bromodeoxyuridine 
(BrdU)-incorporation method in order to evaluate more 
precisely whether the cells responded to NGF after anti- 
sense treatment. PC12 cells were treated for 6 d with 4 ~M 
PON and incubated in the presence of BrdU for the last 40 h 
of  PON  treatment.  In  control  cultures,  we  found  that 
~50%  of the cells incorporated BrdU after 5 d  of NGF 
treatment, whereas ~90% were positive in the absence of 
NGF (Fig. 3). After blockade of stathmin expression with 
antisense PON AS1, the rate of BrdU-incorporation was 
highly increased (P <  0.001) as compared to NGF-treated 
controls  in  the  presence  or  in  the  absence  of nonsense 
PON (Fig. 3). Also, PON AS2 had a highly significant ef- 
fect on NGF-stimulated cessation of proliferation, although 
less prominent than PON AS1, which is consistent with its 
lower efficiency in stathmin depletion (Fig. 3). In control 
experiments, nonsense PON (NS) was ineffective on BrdU- 
incorporation of NGF-treated cultures  (Fig.  3).  Interest- 
ingly, both antisense PONs had a  significant effect (P < 
0.05) on BrdU-incorporation in the absence of NGF, show- 
ing reduced proliferation (Fig. 3). This observation indi- 
cates that stathmin depletion also interferes with cell pro- 
liferation as previously proposed (Marklund et al.,  1994; 
Luo et al., 1994). 
Depletion of Stathmin Does Not Affect Expression  of 
NGF-induced Proteins 
In addition to withdrawal from the cell cycle and morpho- 
logical changes, NGF also stimulates the expression of spe- 
cific proteins in PC12 cells, some of which are the products 
of the so-called "late-induced genes" (for review see Levi, 
1991). To determine whether stathmin is involved in the 
signaling  events  promoted  by NGF resulting  in  specific 
gene expression, we examined the  effect of blockade of 
stathmin expression on the expression of three late-induced 
proteins:  SCG10, which  is  a  neuronal  protein related  to 
stathmin (Stein et al., 1988a,b), VGF8a, a secreted protein 
of unknown  function  (Possenti  et al.,  1989),  and periph- 
erin,  an intermediate  filament protein sharing important 
structural features with neurofllaments (Aletta et al.,  1989). 
After the PC12 cells had been exposed for 5 d  to NGF, 
samples in triplicate were collected and used for Western 
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Figure 3. Effect of stathmin antisense PONs on NGF-induced ces- 
sation of proliferation.  PC12 cell proliferation was measured by 
BrdU-incorporation. The asterisks indicate statistically significant 
differences  (**, P <  0.001; *, P <  0.05). Values denote means -+ 
SEM (n = 3); -  NGF, culture without NGF; + NGF, NGF-stim- 
ulated control;  +  NGF +  AS1/AS2/NS, cultures  with NGF and 
antisense PON AS1, AS2, and nonsense PON, respectively; -  NGF 
+ AS1/AS2/NS, cultures without NGF with antisense PON AS1, 
AS2, and nonsense PON, respectively. After blockade of stathmin 
expression  with  antisense  PONs,  AS1  and  AS2,  NGF-treated 
cells incorporate BrdU at a much higher rate as NGF-treated con- 
trol, whereas nonsense PON is ineffective  on NGF-treated cul- 
tures. In the absence of NGF, both antisense PONs caused a sig- 
nificant decrease of BrdU-incorporation. 
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Figure 4.  Effect of stathmin antisense PON AS1 on expression of NGF- 
induced  proteins.  PC12  cells were  maintained  in  RPM!  1640  supple- 
mented with 1% horse serum and treated as described in Fig. 1. Values 
denote means _  SEM (n =  3, except for VGF8a in the bar height NGF + 
AS, where n  = 2). A shows the induction of three so-called "late-induced 
proteins" after 5 d NGF treatment: SCG10, VGF8a, and peripherin; in 
contrast, stathmin is not upregulated.  B  shows a Western blot analysis 
of protein extracts from cultures incubated with 1% horse serum in the 
absence of NGF (lane 1), in the presence of NGF (lane 2), with 1 tzM 
(lane 3), 2 IxM (lane 4) and 4 ~M (lane 5) antisense PON AS1, with 1 ixM 
(lane 6) and 4 I~M (lane 7) control PON. Blots were incubated with anti- 
bodies specific for stathmin, the three NGF-induced proteins and Gqo~ 
protein, as equal loading marker. C shows protein expression levels of NGF-induced proteins in the presence or absence of 4 ixM anti- 
sense AS1 and controls PONs. The values were obtained from Western blot signals of three different experiments and normalized to the 
equal loading marker, Gqa. The values are expressed as percentages of the samples treated with NGF alone (100%). The graph indi- 
cates that,'in the absence of NGF, relative expression levels of NGF-induced proteins are very low, as shown in Fig. 4 B (lane 1). NGF + 
contr, represents the induction levels in the presence of NGF and nonsense or unrelated control PONs. The expression of the three 
NGF-inducible proteins is significantly induced (P <  0.001, for SCG10 and peripherin) after antisense treatment (NGF +  AS), although 
stathmin levels are downregulated by ~75% in these experiments (Fig. 1). 
blot analysis as described in the experimental procedures. 
Quantitation of the three different markers of differentia- 
tion in control cultures allowed us to confirm that a signifi- 
cant upregulation (6-9-fold) of these proteins, but not of 
stathmin, was promoted by NGF (Fig. 4 A). In parallel ex- 
periments, antisense, nonsense, and unrelated PONs were 
chronically added  to the cultures at  different concentra- 
tions (Fig. 4, B and C). We found that in antisense-treated 
cultures  the  expression of the  three specific markers  of 
PC12 cell differentiation was induced to similar levels as in 
control cultures (Fig. 4, B and C). Thus, despite antisense- 
dependent block of NGF-induced proliferation arrest and 
neurite outgrowth, stathmin-depleted PC12 cells were still 
capable of responding to neurotrophin stimulation with in- 
duction of a range of specific genes. 
NGF-induced Stathmin Phosphorylation Depends on 
MAPK Activation 
To  determine  whether  stathmin  is  a  component  of the 
MAPK  signaling  cascade  initiated  by  NGF,  we  used  a 
pharmacological approach. PD 098059 has recently been 
reported to selectively inhibit the activation of the MAPK- 
activating enzyme (MAPK kinase or MEK), and, conse- 
quently, to prevent the activation of MAPK (Dudley et al., 
1995; Alessi et al., 1995).  In PC12 cells, PD 098059 blocks 
NGF-induced differentiation (Pang et al., 1995). We treated 
PC12 cells for various times with NGF and followed MAPK 
activation and stathmin phosphorylation by Western blot 
analysis. Fig. 5, A and B show that both MAPK- and stath- 
min phosphorylation are strongly induced after 5 rain of 
NGF exposure. After blockade of MAPK activation with 
20 IxM PD 098059 (not shown), stathmin phosphorylation 
was prevented (Fig. 5 C). These results suggest that stath- 
rain is a downstream target for MAPK within the NGF sig- 
naling pathway regulating neuronal differentiation. 
Discussion 
To gain insight into the molecular mechanisms underlying 
the development of the nervous system, we isolated candi- 
date regulatory genes using a subtractive cloning approach 
based on differential gene expression during neurite out- 
growth and synapse formation in the chick embryonic ret- 
ina (Lebeau et al.,  1991).  One of the cDNAs isolated in 
our studies encoded the phosphoprotein stathmin. In this 
report, we describe the characterization of stathmin func- 
tion in antisense-treated PC12 cells.  Our results indicate 
that the protein is absolutely required for NGF-promoted 
differentiation in PC12 cells, although it is not necessary 
for the expression of several NGF-inducible genes. 
PC12 cell differentiation induced by NGF leads to the 
acquisition of neuronal characteristics including cessation 
of proliferation, neurite outgrowth and expression of pro- 
teins  associated  with  neuronal  function.  We  found  that 
chronic blockade of stathmin expression in PC12 cells in- 
hibited NGF-induced morphological changes such as cell 
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pendent on MAPK activity. PC12 cells treated with NGF for 0 min 
(lane 1), 5 min (lane 2), 10 min (lane 3), 30 rain (lane 4), 60 min 
(lane 5), and 180 min (lane 6) were analyzed by Western blotting. 
(A) MAPK activation  was  detected from SDS-lysates  of total 
PC12 cell extracts using phospho-MAPK antibody.  (B) Stathmin 
phosphorylation was detected under native gel electrophoresis con- 
ditions and paralleled MAPK activation in response to NGF. (C) 
In the presence of 20 IxM synthetic inhibitor of the MAPK cascade, 
PD 098059, NGF-induced stathmin phosphorylation was blocked. 
body flattening  and  extension  of processes. To evaluate 
further the loss of responsiveness to NGF after antisense 
treatment, we assessed DNA synthesis using BrdU-incor- 
poration. We found that stathmin depletion of NGF-treated 
PC12 cells resulted in a significantly higher rate of BrdU- 
incorporation suggesting that these cells continued to pro- 
liferate  despite  the  presence  of NGF.  Increased  BrdU- 
incorporation may also result from an abnormal blockade 
in S phase. This phenotype was observed by Marklund et 
al.  (1994)  in an erythroleukemial cell line overexpressing 
both antisense and mutant constructs of stathmin, where 
the  target sites for proline-directed  kinases were deleted. 
However, our experiments showed a significant increase in 
PC12 cell number following antisense treatment suggest- 
ing that increased BrdU incorporation indeed reflects con- 
tinued proliferation. It is also important to note that stathmin 
depletion caused a  significant decrease of proliferation in 
the  absence of NGF, which may reflect a  second role of 
stathmin in proliferating cells. This observation is consistent 
with recent  reports  showing  that  appropriate  expression 
levels and  phosphorylation  of stathmin  are  essential  for 
normal cell division in nonneuronal cell lines (Marklund et 
al., 1994; Luo et al., 1994). Further studies should address 
whether  different states  of stathmin phosphorylation ac- 
count for its dual role in proliferation and differentiation. 
Since chronic inhibition of stathmin expression in undif- 
ferentiated PC12 cells led to an apparent loss of respon- 
siveness to NGF, we determined whether the induction of 
specific markers of PC12 cell neuronal differentiation was 
also inhibited  after antisense  treatment. We tested three 
different proteins which were shown to be highly upregu- 
lated in PC12 cells after NGF induction: SCG10, VGF8a, 
and peripherin. After NGF treatment of stathmin-depleted 
PC12  cells,  which  continued  to  proliferate, the  levels of 
these three proteins increased to control levels. This indi- 
cates that  stathmin is not required  for the  expression of 
the  three NGF-inducible genes. This important observa- 
tion may reflect a  dissociation between morphological or 
cell cycle events and expression of specific markers of neu- 
ronal differentiation. A  similar finding has been described 
in another neuronal cell line, following blockade of microtu- 
bule component MAP2 expression (Dinsmore and Solomon, 
1991).  Our data are consistent with a model of neurotro- 
phin action where different cellular responses characteris- 
tic of neuronal differentiation  are regulated through dis- 
tinct upstream signaling events (for review see Kaplan and 
Stephens, 1994). 
The intracellular pathways stimulated by NGF have been 
extensively studied over the past few years. After stimula- 
tion  of the  high affinity NGF receptor TrkA, one major 
signaling  pathway involves p21ras  and  an  associated  ki- 
nase cascade leading to the  activation of MAPK (for re- 
views see Keegan and Halegoua, 1993; Kaplan and Steph- 
ens,  1994;  Heumann,  1994).  Experiments with  dominant 
negative and constitutively active mutant forms of MAPK 
kinase have shown that activation of MAPK by MAPK ki- 
nase is necessary and sufficient for differentiation of PC12 
cells (Cowley et al., 1994). In addition, inhibition of MAPK 
kinase activity with a small molecular weight inhibitor, PD 
098059, provided further evidence for the requirement of 
the MAPK pathway in PC12 cell differentiation (Pang et 
al., 1995).  Despite the importance of MAPK, it is not clear 
which of the many substrates of MAPKs are responsible 
for specific events associated with proliferation arrest and 
morphological changes. 
Recently, several correlative data suggested that stath- 
min is a physiological substrate for MAPK. First, stathmin, 
which  contains  two  consensus  sites  for  serine/threonine 
proline-directed kinase (Ser25 and 38) has been shown to 
be an in vitro substrate for MAPK (Leighton et al., 1993; 
Marklund et al., 1993). Second, NGF induction leads to a 
rapid and strong phosphorylation of stathmin in PC12 cells 
(Doye et al., 1990), mostly on serine 25 which is the prefer- 
ential site for MAPK (Beretta et al., 1993).  Furthermore, 
the  major  stathmin  kinases  detectable  in  NGF-induced 
PC12 cell extracts were the  two isoforms of MAPK, p42 
and p44 (Leighton et al., 1993). To address the specific po- 
sition  of  stathmin  in  the  NGF  signal  transduction  cas- 
cade(s),  we  analyzed  stathmin  phosphorylation  in  PC12 
cells which have been treated with a selective inhibitor of 
the MAPK cascade, PD 098059. This inhibitor which blocks 
activation of MAPK by NGF in PC12 cells prevented NGF- 
induced  stathmin  phosphorylation.  These  data  provided 
pharmacological evidence that stathmin is a physiological 
substrate for MAPK in the NGF signal transduction path- 
way leading to neuronal differentiation.  Our finding that 
stathmin is not required for induction of the late-induced 
genes indicates that the branching point for expression of 
these genes lies upstream of the MAPK-stathmin interac- 
tion. This is consistent with the fact that transcription  of 
The Journal of Cell Biology, Volume 133,  1996  1388 SCG10  and  VGF8a  can  be  activated  by molecules  up- 
stream of MAPK (D'Arcangelo and Halegoua, 1993).  Fi- 
nally, the  phenotype we  observed in  stathmin  depleted 
PC12 cells is similar to the one of PC12 cells in which nitric 
oxide  synthase  is  inhibited  (Peunova  and  Enikolopov, 
1995). Therefore, it may be interesting for the future to see 
whether induction of nitric oxide synthase is a downstream 
event of the MAPK pathway and whether stathmin is re- 
quired for the induction or activity of this gene. 
We conclude that stathmin is a major regulatory compo- 
nent of the NGF-signaling pathway in PC12 cells mediat- 
ing specific aspects  of neuronal differentiation. In  addi- 
tion,  our subtractive cloning of the  chick gene which  is 
differentially expressed during the period of neurite out- 
growth and synapse formation in the chick retina (Lebeau 
et al.,  1991)  strongly indicates  a  key role in  developing 
neurons in vivo. The identification of proteins that interact 
with stathmin will lead to a  better understanding of the 
molecular interactions underlying neuronal differentiation. 
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Note Added in Proof  After submission of this manuscript, stathmin was 
identified as a protein that interacts with tubulin dimers and increases the 
catastrophe rate of microtubules in vitro (Belmont, L.D., and T.J.  Mitchi- 
son. 1996.  Indentification of a protein that interacts with tubulin dimers 
and  increases the  catastrophe  rate  of  microtubules. Cell.  84:623-631). 
With regard to these data, stathmin may be a link between the NGF signal 
transduction pathway and the modulation of microtubule dynamics. 
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